Osanni Bio
Platform that discovers and de-risks novel drug programs in ophthalmology and cardiology via affiliate company model
$190MSeries B
Role not disclosedLoading investors…
Activity from announced rounds
Platform that discovers and de-risks novel drug programs in ophthalmology and cardiology via affiliate company model